Titre : Ellipticines

Ellipticines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Double-Blind Method
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Ellipticines : Questions médicales les plus fréquentes", "headline": "Ellipticines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Ellipticines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-02", "dateModified": "2025-03-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Ellipticines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carbazoles", "url": "https://questionsmedicales.fr/mesh/D002227", "about": { "@type": "MedicalCondition", "name": "Carbazoles", "code": { "@type": "MedicalCode", "code": "D002227", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.148" } } }, "about": { "@type": "MedicalCondition", "name": "Ellipticines", "alternateName": "Ellipticines", "code": { "@type": "MedicalCode", "code": "D004611", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elaine C O'Sullivan", "url": "https://questionsmedicales.fr/author/Elaine%20C%20O%27Sullivan", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Western Road, Cork T12 K8AF, Ireland." } }, { "@type": "Person", "name": "Florence O McCarthy", "url": "https://questionsmedicales.fr/author/Florence%20O%20McCarthy", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Western Road, Cork T12 K8AF, Ireland." } }, { "@type": "Person", "name": "Hao Lu", "url": "https://questionsmedicales.fr/author/Hao%20Lu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China." } }, { "@type": "Person", "name": "Manli Liu", "url": "https://questionsmedicales.fr/author/Manli%20Liu", "affiliation": { "@type": "Organization", "name": "Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, Wuhan, China." } }, { "@type": "Person", "name": "Wenjia Lu", "url": "https://questionsmedicales.fr/author/Wenjia%20Lu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Individualized Homeopathic Medicines in the Treatment of Psoriasis Vulgaris: Double-Blind, Randomized, Placebo-Controlled Trial.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37263249", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000530180" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial.", "datePublished": "2022-09-22", "url": "https://questionsmedicales.fr/article/36136861", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MPG.0000000000003622" } }, { "@type": "ScholarlyArticle", "name": "Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study.", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35896988", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s10194-022-01458-0" } }, { "@type": "ScholarlyArticle", "name": "The minimal important difference in obsessive-compulsive disorder: An analysis of double-blind SSRI trials in adults.", "datePublished": "2024-09-20", "url": "https://questionsmedicales.fr/article/39301594", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1192/j.eurpsy.2024.1768" } }, { "@type": "ScholarlyArticle", "name": "A Dietary Supplement in the Management of Patients with Lumbar Osteochondrosis: A Randomized, Double-Blinded, Placebo-Controlled Study.", "datePublished": "2024-08-14", "url": "https://questionsmedicales.fr/article/39203831", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/nu16162695" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Carbazoles", "item": "https://questionsmedicales.fr/mesh/D002227" }, { "@type": "ListItem", "position": 6, "name": "Ellipticines", "item": "https://questionsmedicales.fr/mesh/D004611" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Ellipticines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Ellipticines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Ellipticines", "description": "Comment diagnostiquer une tumeur sensible aux ellipticines ?\nQuels tests sont utilisés pour évaluer l'efficacité des ellipticines ?\nLes ellipticines sont-elles utilisées pour tous les types de cancer ?\nQuels signes cliniques indiquent un traitement par ellipticines ?\nComment évaluer les effets secondaires des ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Double-Blind+Method&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Ellipticines", "description": "Quels symptômes peuvent indiquer un cancer traité par ellipticines ?\nLes ellipticines provoquent-elles des effets secondaires ?\nComment reconnaître une réaction allergique aux ellipticines ?\nLes ellipticines affectent-elles le système immunitaire ?\nQuels signes indiquent une toxicité des ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Double-Blind+Method&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Ellipticines", "description": "Peut-on prévenir les cancers traités par ellipticines ?\nQuels facteurs de risque sont associés aux cancers traités par ellipticines ?\nLes vaccinations peuvent-elles aider à prévenir le cancer ?\nComment un mode de vie sain influence-t-il le risque de cancer ?\nLes examens de santé réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Double-Blind+Method&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Ellipticines", "description": "Comment les ellipticines sont-elles administrées ?\nLes ellipticines sont-elles utilisées en monothérapie ?\nQuel est le mécanisme d'action des ellipticines ?\nQuelles sont les alternatives aux ellipticines ?\nComment surveiller l'efficacité du traitement par ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Double-Blind+Method&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Ellipticines", "description": "Quelles complications peuvent survenir avec les ellipticines ?\nLes ellipticines peuvent-elles causer des dommages aux organes ?\nComment gérer les effets secondaires graves des ellipticines ?\nLes ellipticines augmentent-elles le risque de récidive du cancer ?\nQuels sont les risques de surdosage d'ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Double-Blind+Method&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Ellipticines", "description": "Quels sont les principaux facteurs de risque pour les cancers traités par ellipticines ?\nL'hérédité joue-t-elle un rôle dans le risque de cancer ?\nL'alimentation influence-t-elle le risque de cancer ?\nLe stress est-il un facteur de risque pour le cancer ?\nLes infections virales augmentent-elles le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Double-Blind+Method&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur sensible aux ellipticines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic est établi par biopsie et analyses histopathologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité des ellipticines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie comme l'IRM et des marqueurs tumoraux sont utilisés." } }, { "@type": "Question", "name": "Les ellipticines sont-elles utilisées pour tous les types de cancer ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont principalement efficaces contre certains cancers comme le cancer du poumon." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un traitement par ellipticines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de progression tumorale ou de résistance aux autres traitements peuvent indiquer leur utilisation." } }, { "@type": "Question", "name": "Comment évaluer les effets secondaires des ellipticines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires sont évalués par des examens cliniques et des questionnaires de qualité de vie." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un cancer traité par ellipticines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, fatigue, perte de poids et changements d'appétit." } }, { "@type": "Question", "name": "Les ellipticines provoquent-elles des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent causer nausées, vomissements, et troubles hématologiques." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique aux ellipticines ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons ou gonflements peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Les ellipticines affectent-elles le système immunitaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner une immunosuppression, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Quels signes indiquent une toxicité des ellipticines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de toxicité incluent fatigue extrême, saignements inhabituels et jaunisse." } }, { "@type": "Question", "name": "Peut-on prévenir les cancers traités par ellipticines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures préventives incluent un mode de vie sain et des dépistages réguliers." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux cancers traités par ellipticines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'exposition à des agents carcinogènes et des antécédents familiaux." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider à prévenir le cancer ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancer." } }, { "@type": "Question", "name": "Comment un mode de vie sain influence-t-il le risque de cancer ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant alimentation équilibrée et exercice, peut réduire le risque." } }, { "@type": "Question", "name": "Les examens de santé réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils permettent de détecter précocement des anomalies et d'initier un traitement rapide." } }, { "@type": "Question", "name": "Comment les ellipticines sont-elles administrées ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement administrées par voie intraveineuse ou orale." } }, { "@type": "Question", "name": "Les ellipticines sont-elles utilisées en monothérapie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être utilisées seules ou en association avec d'autres traitements anticancéreux." } }, { "@type": "Question", "name": "Quel est le mécanisme d'action des ellipticines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elles agissent en interférant avec l'ADN des cellules cancéreuses, inhibant leur prolifération." } }, { "@type": "Question", "name": "Quelles sont les alternatives aux ellipticines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les alternatives incluent d'autres chimiothérapies, thérapies ciblées et immunothérapies." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement par ellipticines ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est surveillée par des examens d'imagerie et des bilans sanguins réguliers." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les ellipticines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des saignements et des réactions allergiques." } }, { "@type": "Question", "name": "Les ellipticines peuvent-elles causer des dommages aux organes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des toxicités hépatiques et rénales, nécessitant une surveillance." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires graves des ellipticines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut l'ajustement de la dose, l'utilisation de médicaments symptomatiques et le suivi." } }, { "@type": "Question", "name": "Les ellipticines augmentent-elles le risque de récidive du cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire le risque de récidive, mais un suivi régulier est essentiel." } }, { "@type": "Question", "name": "Quels sont les risques de surdosage d'ellipticines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le surdosage peut entraîner des effets toxiques graves, nécessitant une intervention médicale immédiate." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour les cancers traités par ellipticines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'âge." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans le risque de cancer ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer augmentent le risque de développer certaines tumeurs." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque de cancer ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque pour le cancer ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Bien que le stress ne soit pas un facteur direct, il peut affecter le système immunitaire." } }, { "@type": "Question", "name": "Les infections virales augmentent-elles le risque de cancer ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections virales, comme le HPV, sont liées à un risque accru de cancer." } } ] } ] }

Sources (10000 au total)

Individualized Homeopathic Medicines in the Treatment of Psoriasis Vulgaris: Double-Blind, Randomized, Placebo-Controlled Trial.

Psoriasis is a chronic inflammatory skin disorder, affecting the trunk and extensor surfaces of the limbs and scalp predominantly. Worldwide prevalence ranges between 0.1 and 11.4%, and in India betwe... This 6-month, double-blind, randomized trial was conducted on 51 patients suffering from psoriasis at the National Institute of Homoeopathy, India. Patients were randomized to receive either individua... Although intragroup changes were significant in both groups in the outcome measures, improvements were significantly higher in the IHMs group than in placebos in PASI scores after 6 months of interven... IHMs exhibited better results than placebos in the treatment of psoriasis. Further research is warranted.... <title>Einleitung</title>Psoriasis ist eine chronisch entzündliche Hauterkrankung, die vor allem den Körperstamm und die Streckseiten der Extremitäten sowie die Kopfhaut betrifft. Die weltweite Präval...

Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial.

Pediatric irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with variable response to various therapeutic agents. Psyllium has been proven to be effective in adults; howe... In this double-blind randomized controlled trial, 43 children were assigned to psyllium arm (Group A) and 38 into placebo arm (Group B). Severity is assessed at baseline and after 4 weeks of treatment... Mean ages (±SD; in years) of Groups A and B were 9.87 (2.7) and 9.82 (3.17), respectively, with median duration of illness of 12 months. At baseline, type, severity, and parameters (IBS-SSS) of IBS we... Psyllium husk is effective for the therapy of pediatric IBS when compared with placebo in short term....

Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study.

Galcanezumab, a humanized monoclonal antibody that binds calcitonin gene-related peptide, has demonstrated efficacy and good tolerability in patients with episodic migraine in previous phase 3 trials.... This phase 3 study was conducted at 40 centers in China (n = 26), India (n = 10), and Russia (n = 4). Eligible adult patients with episodic migraine were randomized in a 1:1 ratio to receive monthly g... In total, 520 patients were randomized and received at least one dose of galcanezumab (N = 261) or placebo (N = 259). The least squares (LS) mean reduction from baseline in monthly MHDs over 3 months ... Galcanezumab 120 mg once monthly was effective and well tolerated in patients with episodic migraine from China, India, and Russia.... ClinicalTrials.gov Identifier NCT03963232 (PERSIST), registered May 24, 2019....

The minimal important difference in obsessive-compulsive disorder: An analysis of double-blind SSRI trials in adults.

The change in symptoms necessary to be clinically relevant in obsessive-compulsive disorder (OCD) is currently unknown. In this study, we aimed to create an empirically validated threshold for clinica... We analyzed individual participant data from short-term, double-blind, placebo-controlled registration trials of selective serotonin reuptake inhibitors in adult OCD patients. Data were collected from... We included 7 trials with a total of 1216 patients. The CGI-scores and YBOCS were moderately to highly correlated. The MID corresponded to 4.9 YBOCS points (95% CI 4.4-5.4) for the full sample, or a 2... By linking the YBOCS to the CGI-I, this is the first study to propose an MID in OCD trials. Having a clearly defined MID can guide future clinical research and help interpretation of efficacy of exist...

The clinical effect of benesco™ on reflux symptoms: A double-blind randomized placebo-controlled trial.

Gastroesophageal reflux disease (GERD) is one of the most prevalent gastrointestinal diseases in the western world. Lifestyle modifications and proton pump inhibitors (PPIs) form the basis of the mana... We performed a double-blind randomized placebo-controlled trial in participants with reflux symptoms. Participants were assigned randomly (1:1) to receive 6 weeks of benesco™ (three times daily one lo... One hundred participants were randomized. Treatment success was seen in 18 (39%) of 46 participants in the intervention group versus 21 (47%) of 45 in the placebo group (p = 0.468). In the interventio... In our trial benesco™ showed no significant benefit over placebo at group level....

Turpentine Ointment in Bacterial Skin Infections: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Turpentine-containing substances are considered effective in treating cutaneous bacterial infections, but reliable clinical data are scant.... We investigated the efficacy and safety of an ointment containing larch turpentine (from Larix decidua), eucalyptus oil (from Eucalyptus globulus), and turpentine oil (from Pinus pinaster) in outpatie... 116 outpatients with skin abscesses used verum or placebo for 10 days. Sum score of the patient's discomforts, changes in abscess size, rate of therapeutic success, and complete healing served as outc... Fifty-four patients were treated with verum and 56 with placebo. According to the patient's discomfort sum score, patients in the verum group showed a better improvement compared to the placebo group ... The ointment studied is an effective and safe option for the treatment of bacterial skin diseases....

Individualized Homeopathic Medicines in Treatment of Hyperuricemia: Evaluation by Double-Blind, Randomized, Placebo-Controlled Trial.

Hyperuricemia (HU) is a major health issue in India and across the globe. It increases the disease burden and hampers quality of life. This study was aimed at exploring the effects of individualized h... This double-blind, randomized, placebo-controlled trial was conducted on 60 patients suffering from HU in the outpatient department of D. N. De Homoeopathic Medical College and Hospital, Kolkata. Each... The intention-to-treat sample (... IHMs showed significantly better results than placebos in reducing SUA levels and improving quality of life in patients suffering from HU.... CTRI/2019/10/021503; UTN: U1111-1241-1431....

Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial.

Tinea corporis (TC; ringworm or dermatophytosis) is a superficial skin infection caused by... A double-blind, randomized, placebo-controlled, two parallel arms trial was conducted on 62 individuals suffering from TC at the National Institute of Homoeopathy, India. Participants were randomized ... The primary outcome revealed no improvement in either of the groups (... Results were negative on the primary outcome; however, secondary outcomes included some statistically significant results favoring IHMs against placebo after 3 months.... CTRI/2019/11/021999; UTN: U1111-1242-0070....